A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: the example of glycated haemoglobin in Type 2 Diabetes by Redazione | Lug 17, 2023
Patients with heart failure eligible to a SGLT2 inhibitor treatment: prevalence, characteristics and costs from a combination of administrative healthcare and primary care databases by Redazione | Dic 14, 2022
How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases by Redazione | Dic 14, 2022
